Cargando…

Experimental study on the regulation of erlotinib-induced radiosensitization with an anti-c-MET monoclonal antibody

PURPOSE: Erlotinib is a novel therapeutic agent for cancer treatment. This study was performed to investigate the role of c-MET-PI3K-AKT pathway in the regulation of erlotinib-induced radiosensitization. METHODS: A973 lung adenocarcinoma cells treated with 6 Gy of radiation were incubated in the pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Hong-Qing, Zhuang, Hongxia, Bo, Qifu, Guo, Yihang, Wang, Jun, Zhao, Lu-Jun, Yuan, Zhi-Yong, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263203/ https://www.ncbi.nlm.nih.gov/pubmed/25505849 http://dx.doi.org/10.1186/s12935-014-0109-5

Ejemplares similares

The different radiosensitivity when combining erlotinib with radiation at different administration schedules might be related to activity variations in c-MET-PI3K-AKT signal transduction
por: Zhuang, Hong-Qing, et al.
Publicado: (2013)

Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
por: Münz, Markus, et al.
Publicado: (2010)

OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair
por: Wu, Zhiqiang, et al.
Publicado: (2019)

The radiosensitization effects of Endostar on human lung squamous cancer cells H-520
por: You, Zhen Y, et al.
Publicado: (2010)

Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect
por: Yamada, Kohji, et al.
Publicado: (2009)

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
por: Cavazzoni, Andrea, et al.
Publicado: (2012)

IFI35 is involved in the regulation of the radiosensitivity of colorectal cancer cells
por: Hu, Yan, et al.
Publicado: (2021)

The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR
por: Tan, Biqin, et al.
Publicado: (2020)

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
por: Wang, Jieyi, et al.
Publicado: (2016)

Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC-1 cell apoptosis via activating the mROS-HtrA2/Omi pathways
por: Wan, Jun, et al.
Publicado: (2018)

CD40 monoclonal antibody and OK432 synergistically promote the activation of dendritic cells in immunotherapy
por: Zhang, Juan, et al.
Publicado: (2022)

Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells
por: Lin, Yanzhu, et al.
Publicado: (2019)

A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition
por: Hayashi, Mutsumi, et al.
Publicado: (2016)

EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells
por: Zhang, Yingdong, et al.
Publicado: (2010)

Circular RNA circPITX1 knockdown inhibits glycolysis to enhance radiosensitivity of glioma cells by miR-329-3p/NEK2 axis
por: Guan, Yongchang, et al.
Publicado: (2020)

Effect of Ku70 expression on radiosensitivity in renal carcinoma 786-O cells
por: Qi, Defeng, et al.
Publicado: (2014)

LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway
por: Wang, Chen, et al.
Publicado: (2020)

Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells
por: Velazquez, Edwin J., et al.
Publicado: (2020)

MicroR-545 enhanced radiosensitivity via suppressing Ku70 expression in Lewis lung carcinoma xenograft model
por: Liao, Chen, et al.
Publicado: (2015)

The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines
por: de Andrade, Pamela Viani, et al.
Publicado: (2016)

Inhibition of Delta-like Ligand 4 enhances the radiosensitivity and inhibits migration in cervical cancer via the reversion of epithelial–mesenchymal transition
por: Yang, Shan-Shan, et al.
Publicado: (2020)

The experimental study of shunt-decompression arterialized vein flap
por: Li, Zheng, et al.
Publicado: (2018)

pATM and γH2AX are effective radiation biomarkers in assessing the radiosensitivity of (12)C(6+) in human tumor cells
por: Zhao, Jin, et al.
Publicado: (2017)

Molecular mechanism study of HGF/c-MET pathway activation and immune regulation for a tumor diagnosis model
por: Shen, Zhibo, et al.
Publicado: (2021)

Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells
por: Huang, Keqiang, et al.
Publicado: (2018)

Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma
por: Zhuang, Hongqing, et al.
Publicado: (2013)

Expression of MACC1 and c-Met in human gastric cancer and its clinical significance
por: Guo, Tiankang, et al.
Publicado: (2013)

DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway
por: Tong, Zhuting, et al.
Publicado: (2022)

SOCS6 promotes radiosensitivity and decreases cancer cell stemness in esophageal squamous cell carcinoma by regulating c-Kit ubiquitylation
por: Sun, Xuanzi, et al.
Publicado: (2021)

Long noncoding RNA LINC00958 suppresses apoptosis and radiosensitivity of colorectal cancer through targeting miR-422a
por: Liang, Hong, et al.
Publicado: (2021)

TRIM27 promotes the development of esophagus cancer via regulating PTEN/AKT signaling pathway
por: Ma, Liang, et al.
Publicado: (2019)

Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification
por: Zhao, Zhi-Mei, et al.
Publicado: (2021)

Long noncoding RNA LINC01510 promotes the growth of colorectal cancer cells by modulating MET expression
por: Cen, Chaoqun, et al.
Publicado: (2018)

Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients
por: Wulandari, Laksmi, et al.
Publicado: (2021)

Lattice complex assembled by noncompetitive anti-EGFR antibodies regulates actin cytoskeletal reorganization
por: Huang, Dianshuai, et al.
Publicado: (2020)

Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
por: Buchanan, Ian M, et al.
Publicado: (2011)

MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
por: Ramesh, Shrey, et al.
Publicado: (2023)

MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023)

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5u2fqisi01s44crjsapb1m46r7